Seema Capoor - University of Kentucky

Education/Academic qualification

Residency, Royal College of Ophthalmologists, London, England

1999

Doctor of Medicine, Charing Cross & Westminster Med

1990

Bachelor of Science, University Of London

1987

2 Active
3 Finished

A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Simultane
Capoor, S. (PI)
PPD Investigator Services LLC
7/12/23 → 7/12/25
Project: Research project
K-321-301 : A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops Aft
Capoor, S. (PI)
PPD Investigator Services LLC
6/22/23 → 6/22/25
Project: Research project
A 6 Day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and Efficacy of Gatifloxacin 0.5% Ophthalmic Solution BID with that of Vehicle in the Treatment of Acute Bacterial Conjunctivitis
Capoor, S. (PI)
Allergan Pharmaceuticals Inc
10/1/08 → 12/31/08
Project: Research project
A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis
Capoor, S. (PI) & Conklin, J. (CoI)
Bausch and Lomb
9/6/06 → 8/31/08
Project: Research project
Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 52-Week Study
Capoor, S. (PI) & VanMeter, W. (CoI)
Otsuka Maryland Research Institute Inc
7/9/04 → 6/30/06
Project: Research project